ArticleBMC geriatrics2025
Mediating role of possible sarcopenia in the association between diabetes and stroke: finding from the China health and retirement longitudinal study.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The vasoprotective role of Myeloid-derived suppressor cells in pathogenesis of aortic dissection.Scientific reports · 2026Article
- Predicting fall risk among older adults with sarcopenia in China using machine learning models: a six-year longitudinal study from CHARLS.BMC geriatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundDiabetes and sarcopenia were risk factors for the development of stroke. The presence of diabetes increased the likelihood of developing sarcopenia. No prior study has investigated the potential mediating role of sarcopenia in the association between diabetes and stroke risk. In this study, we aimed to explore the mediating effect of possible sarcopenia between diabetes and stroke, utilizing data from China Health and Retirement Longitudinal Study (CHARLS).
methodsIn this retrospective cohort study, we included 3,997 individuals aged ≥ 65 years old from CHARLS database of 2015, followed up until 2018. The study outcome was the stroke incident. Possible sarcopenia was defined based on the Asian Working Group on Sarcopenia 2019 criteria: low muscle strength with or without reduced physical performance. The observation period for the outcome event was in 2018, while other baseline data were collected in 2015. The relationship between diabetes, possible sarcopenia and stroke were examined by univariate and multivariate logistic regression models. Distribution-of-product method was used to test the mediating effect. P < 0.05 was considered statistically significant for this study.
resultsThe incidence of stroke in the studied populations was approximately 7.11%. The result of multivariate logistic regression analysis indicated that diabetes was related to an increased stroke risk [total effect: adjusted odds ratio (OR) = 1.37, 95% confidence interval (CI): 1.04-1.82)], and a higher risk of possible sarcopenia (adjusted OR = 1.21, 95% CI: 1.02-1.43). Additionally, possible sarcopenia was identified as being linked to an associated with stroke risk (adjusted OR = 1.31, 95% CI: 1.01-1.70). Using the distribution-of-product test, a potential mediating effect of possible sarcopenia on the relationship between diabetes and stroke was observed (indirect effect: adjusted OR = 1.062, 95%CI: 1.003-1.156), with a 95% CI for distribution-of-product of 0.060 (95% CI: 0.003-0.145). The percentage of the mediating effect of 5.41%.
conclusionPossible sarcopenia partially mediates the association between diabetes and stroke. This finding provides evidence underscoring the significance of maintaining and improving stroke by somewhat reducing the risk of possible sarcopenia, particularly in populations with diabetes. Future studies should focus on understanding the mechanisms underlying these associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.